Stay updated on Crenolanib with Salvage Chemo in R/R AML Clinical Trial
Sign up to get notified when there's something new on the Crenolanib with Salvage Chemo in R/R AML Clinical Trial page.

Latest updates to the Crenolanib with Salvage Chemo in R/R AML Clinical Trial page
- Check7 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a pilot study involving crenolanib for treating Relapsed/Refractory Acute Myeloid Leukemia (AML) and the addition of new drug names such as Etoposide, Fludarabine, and Idarubicin. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference40%
- Check14 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.5%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedDifference0.5%
- Check44 days agoChange DetectedDifference0.5%
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check65 days agoChange DetectedDifference0.8%
Stay in the know with updates to Crenolanib with Salvage Chemo in R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenolanib with Salvage Chemo in R/R AML Clinical Trial page.